Akili is in the process of building clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like high-quality video games. Their aim is to develop a new type of Digital Medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians. Akili functions on the premise that advances in neuroscience research and consumer-facing technology are enabling a new way to sensitively measure neural function, and intervene in any measured deficits, wherever the patient may be. Akili's products address both quantitative measurement of and intensive intervention in cognitive functions in a variety of patient populations. Akili was co-founded by PureTech, leading cognitive neuroscientists, and top-tier entertainment software creators.